Mark Clemons

Medical Oncologist and Professor

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Mark Clemons is a Medical Oncologist and Professor at The Ottawa Hospital and the University of Ottawa, Canada. His research focuses on the management of breast cancer and prostate cancer, particularly in relation to chemotherapy-induced symptoms and bone-modifying agents. Recent publications have addressed topics such as the clinical utility of prediction tools for chemotherapy side effects and the efficacy of treatment strategies for managing pain in breast cancer patients.

Articles (9)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mark Clemons

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancers

Clinical utility of a prediction tool to differentiate between breast cancer patients at high or low risk of chemotherapy-induced nausea and vomiting

A prospective multi-centre, randomized study comparing the addition of tapering dexamethasone to other standard of care therapies for taxane-associated pain syndrome (TAPS) in breast cancer patients

Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey

A randomized clinical trial comparing physician-directed or fixed-dose steroid replacement strategies for incomplete dexamethasone dosing prior to docetaxel chemotherapy

Lost in transition? Thoughts on Retirement Part 2. “Should I stay or should I go now?”

A scoping review characterizing "Choosing Wisely®" recommendations for breast cancer management

A randomized trial comparing vascular access strategies for patients receiving chemotherapy with trastuzumab for early-stage breast cancer

Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307

Make your next move.